GRCE (Grace Therapeutics) Tax Rate %: 59.07% (As of Mar. 2026)


GRCE Grace Therapeutics Inc GRCE
31 GF Score
Price $2.53
! 2 Warning Signs
View Full Analysis

What is Grace Therapeutics Tax Rate %?

Grace Therapeutics GRCE -0.79% 31 Tax Rate % is 59.07% as of Mar. 2026. GuruFocus rates GRCE with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Grace Therapeutics's Tax Expense for the three months ended in Mar. 2026 was $-1.70 Mil. Grace Therapeutics's Pre-Tax Income for the three months ended in Mar. 2026 was $-2.88 Mil. Therefore, Grace Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 was 59.07%.

Grace Therapeutics Tax Rate % Related Terms

Grace Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Grace Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grace Therapeutics Tax Rate % Chart

Grace Therapeutics Annual Data
Trend Feb16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.19 18.36 12.48 25.06 17.91

Grace Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 266.49 0.00 0.00 0.00 59.07
GRCE
31GF Score
Grace Therapeutics Inc GRCE
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grace Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Grace Therapeutics's Tax Rate % for the fiscal year that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (A: Mar. 2026 )/Pre-Tax Income (A: Mar. 2026 )
=-1.7/-9.493
=17.91 %

Grace Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=-1.7/-2.878
=59.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 59.07% mean?
Grace Therapeutics (GRCE) has a Tax Rate % of 59.07% as of Mar. 2026.
Is Grace Therapeutics' Tax Rate % too high?
Grace Therapeutics' current Tax Rate % is 59.07%. Overall, Grace Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Grace Therapeutics' Tax Rate % compare to INMB and ABVC?
Grace Therapeutics' Tax Rate % of 59.07% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Grace Therapeutics's current Tax Rate % is 59.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grace Therapeutics stock overvalued right now?
Grace Therapeutics (GRCE) has a current Tax Rate % of 59.07%. The current Tax Rate % is 59.07%. Grace Therapeutics' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Grace Therapeutics (GRCE), the current Tax Rate % is 59.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grace Therapeutics Business Description

Address 103 Carnegie Center, Suite 300, Princeton, NJ, USA, 08540
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage (aSAH); GTx-102, targeted for the treatment of ataxia-telangiectasia (A-T) in a pediatric population; and GTx-101, a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia (PHN), which can be persistent and often causes debilitating pain following infection by the shingles virus. The company has one reportable operating segment: the development and commercialization of pharmaceutical applications of its patents and licensed rights.
31GF Score

Get the complete analysis for GRCE

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.53
Price